1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J]. CA Cancer J Clin,2009,59(4) :225-249.
2Morgan M, Sun M, Johal R, et al. The rates of metastatic renal ceil carcinoma are decreasing over time: A population based analy sis[J]. Can Urol Assoc J,2010,4(3 Snppl 1) :S3-S94.
3Ku JH, Moon KC, Kwak C, et al. External validation of an in ternational multicenter study to predict survival in Korean patients with pT2NOM0 renal cell carcinoma [J]. Urology, 2009,74 (2) : 359-363.
4Klatte T, Patard JJ, Goel RH, et al. Prognostic impact of tumor size on pT2 renal cell carcinoma:an international multicenter expe rience[J]. Nat Clin Pratt Urol,2007,4(12) :648-649.
5Ficarra V, Novara G, Iafrate M, et al. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3 4) renal cell carcinoma according to the cancer-related out come[J]. Eur Urol,2007,51(3) :722-731.
6Kim HL, Zisman A, Han KR, et al. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? [J]. J Urol, 2004, 171(2 Pt 1):588-591.
7Kresowik TP, Johnson MT, Joudi FN. Combined renal sinus fat and perinephric fat renal ceil carcinoma invasion has a worse prog nosis than either alone[J]. J Urol,2010,184(1):48-52.
8Bertini R, Roscigno M, Freschi M, et al. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastasesl[J]. J Urol,2009, 81(5):2027-2032.
9Blom JH, van Poppel H, Marechal JM, et al. Radical ne phrectomy with and without lymph node dissection: prelimi nary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Groulo[J]. Eur Uro1,1999,36 (6):570-575.
10Minervini A, l.ilas I., Morelli C, et al. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during sur gery?[J]. BJU Int,2001,88(3):169-172.
3KUCZYK M, WEGENER G, JONAS U. The thera peutic value of adrenalectomy in case of solitary meta static spread originating from primary Renal cell cane er[J]. European Urology, 2005, 48 : 252-257.
4SIMON P K, CHRISTOPHER J M, BRADLEY C L, et al. Outcomed and clinicopa thologic variables associated with late recurrence after nephrectomy fkr localiged Renal cell carcinoma[J]. Urology, 2011, 78 (5) : 1101-1105.
5叶敞 江淳.肿瘤(癌)微转移的定义.实用癌症杂志,2011,26(5):533-533.
6吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.
7Boorjian SA, Uzzo RG. The evolving management of small renal masses. Current oncology reports, 2009, 11 (3) : 211-217.
8Reddan DN, Raj GV, Polascik TJ. Management of small renal tumors : an overview.Am J Med, 2001, 110(7) : 558-562.
9Jiang J, Chen Y, Zhou Y, et al. Clear cell renal cell carcinoma: contrast-enhanced ultrasound features relation to tumor size.Eur J Radiol, 2010, 73( 1 ) : 162-167.
10Patard JJ, Tazi H, Bensalah K, et al. The changing evolution of renal tumours: a single center experience over a two-decade pefiod.Eur Urol, 2004, 45(4): 490-494.
